• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-032
Device Problem Unintended Movement (3026)
Patient Problem No Information (3190)
Event Date 06/14/2018
Event Type  Injury  
Manufacturer Narrative
Product #1 pi main [(b)(4)] an event of device embolization was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined; however, information from the field indicates, "the patient had heavy physical activity on the day of embolization and was thought to be the reason." per ifu, patients should avoid strenuous activities for a minimum of 1 month post-device implant.Strenuous activities may lead to the increased risk of adverse events.A 34 mm amplatzer atrial septal occluder was used for replacement.
 
Event Description
On (b)(6) 2018, a 32 mm amplatzer atrial septal occluder was implanted.On (b)(6) 2018, the device was found to have embolized and was retrieved by snare; the patient was reported stable after.Per report, the patient had heavy physical activity on the day of embolization, which was 8 days after implant.The physical activity is thought to be the reason for embolization.On (b)(6) 2018, a redo procedure was successfully completed with a 34 mm amplatzer atrial septal occluder.The patient was reported stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
elizabeth boltz
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key7710693
MDR Text Key114720347
Report Number2135147-2018-00093
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010236
UDI-Public00811806010236
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Model Number9-ASD-032
Device Catalogue Number9-ASD-032
Device Lot Number6273525
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/25/2018
Initial Date FDA Received07/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age42 YR
Patient Weight101
-
-